West Pharmaceutical Services, Inc. (NYSE:WST ) Q3 2022 Earnings Conference Call October 27, 2022 9:00 AM ET Company Participants Quintin Lai – Vice President-Investor Relations Eric Green – Chief
The company reported disappointing Q3 results.
West Pharmaceutical's (WST) third-quarter results reflect sustained growth in non-COVID-19 demand amid dismal overall performance.
West Pharmaceutical (WST) delivered earnings and revenue surprises of -4.25% and 5.99%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

My Best Dividend Aristocrats For November 2022

02:26pm, Wednesday, 26'th Oct 2022
NOBL fell 9.15% in September, which brings the Funds return for the year to a loss of 17.47%. Thus far this month, through October 24th, the dividend aristocrat ETF is up 6.04%, bringing its year-to-d
West Pharmaceutical's (WST) third-quarter results are likely to reflect strength in the Proprietary Products business. However, unfavorable currency movements are likely to hurt the top and bottom lin
West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex woes persist.
Expert presentations and posters offer thought leadership in drug delivery innovation, patient adherence and pharmaceutical manufacturing EXTON, Pa. , Oct. 18, 2022 /PRNewswire/ --  West Pharmaceutic

West to Host Third-Quarter 2022 Conference Call

06:00am, Thursday, 13'th Oct 2022
EXTON, Pa. , Oct. 13, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will rel

My Best Dividend Aristocrats For October 2022

06:47pm, Monday, 26'th Sep 2022
NOBL fell 2.78% in August which brings the Funds return for the year to a loss of 9.16%. Thus far, through September 23rd, the dividend aristocrat ETF is down 6.71%, bringing its year-to-date return t
West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex woes persist.
EXTON, Pa. , Sept. 8, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will part
West Pharmaceutical Services, Inc. (NYSE:WST ) Q2 2022 Earnings Conference Call July 28, 2022 9:00 AM ET Company Participants Quintin Lai – Vice President, Investor Relations Eric Green – Chief Ex

West to Host Second-Quarter 2022 Conference Call

05:00pm, Thursday, 14'th Jul 2022
EXTON, Pa. , July 14, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will rele
West Pharmaceutical Services has performed extraordinarily well in recent years. The future of the enterprise looks bright and the company will likely continue to fare well in the years to come.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE